Innovative Partnerships for Drug Discovery against Neglected Diseases
2011
Innovative Partnerships for Drug Discovery against Neglected Diseases
publication
Evidence: moderate
Author Information
Author(s): Jakobsen Palle H., Wang Ming-Wei, Nwaka Solomon
Hypothesis
How can innovative partnerships improve drug discovery for neglected diseases?
Conclusion
Innovative public-private partnerships are essential for developing new drugs for neglected diseases.
Supporting Evidence
- There is a scarcity of effective treatments for neglected diseases despite their high prevalence.
- Public-private partnerships can significantly reduce the cost of drug development.
- Collaborative research environments can enhance the efficiency of drug discovery.
Takeaway
This study talks about how different organizations can work together to create new medicines for diseases that are often ignored. By sharing resources and knowledge, they can help people in need.
Methodology
The study discusses various collaborative models and partnerships in drug discovery for neglected diseases.
Limitations
The study highlights the challenges in funding and the lack of commercial market for neglected diseases.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website